ArticleDiscover oncology2025

Integrated single-cell and Mendelian randomization analyses: dissecting underlying causes of varied efficacy in immune neoadjuvant therapy for esophageal carcinoma.

Jiaxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.